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are at work fo r  cellular antigens also. This confirms their  im- 
portance in possible manipulations of  ant i - tumor immune  
response [36 ,37 ] .  
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U. Koszinowski and R. Thomssen Target cell-dependent T cell-mediated lysis of vaccinia 
v i r us- i nf ected ce I Is 
lnstitut fur Hygiene und Medizinische 
Mikrobiologie der Universitat Gottingen 
Vaccinia virus specific cytotoxicity against infected target cells was observed 
in vitro. Spleen lymphocytes  f rom normal and immunized mice of t he  inbred 
strains C3H and DBA/2 were incubated with vaccinia virus-infected and  non- 
infected 5 1  Cr-labeled mastocytoma P-815-X2 cells a n d  L-929 fibroblasts, which 
were used as targets., Cytotoxic  lymphocytes  could be isolated from t h e  mice as 
early a s  2 days af ter  infection with vaccinia virus. The  highest cytotoxic  effect 
was obtained with lymphocytes  taken 6 days af ter  infection. The  degree of lysis 
was correlated with t h e  ratio o f  immune  lymphocytes  t o  target cells. Specific 
blocking of  target cell lysis resulted af ter  addi t ion of anti-vaccinia ant ibody 
f rom different sources. The  effector cells could be  characterized as T cells by 
elimination o f  macrophages and B cells. Target cell killing was only possible in 
a syngeneic system ; allogeneic infected target cells were not  lysed significantly. 
[I 9741 1 .  Introduction 
Correspondence: Ulrich Koszinowski, Institut f ir  Hygiene und Medizi- 
nische Mikrobiologie der Universitat Gottingen, D-34 Gottingen, Kreuz- 
bergring 57, Fed. Rep. Germany 
Cell-mediated immune mechanisms play an essential role in 
resistance to viral infections [ 1 -41, Lymphocyte  transforma- 
t ion and  migration inhibition tests have been adop ted  t o  
evaluate the  interactions between virus and lymphocytes.  To 
demonstrated making i t  necessary to specify transformation 
tests with respect t o  t h e  action of B and T cells. Furthermore,  
these tests give no evidence abou t  t he  specific action of T cells 
Abbreviations. B Cell: Antibody-forming Cell precursor CL: Cytotoxic prove cell-mediated immunity, the effect of T cells has to be 
lymphocytes CMI: Cell-mediated immunity FCS: Fetal calf serum 
Lps: Lipopolysaccharide MEM: Eagle,s essential medium 
p w ~ :  pokeweed mitogen p w :  phytohemagglutinin T 
derived cell TCID: Tissue culture infective dosis 
Thymus 
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on virus particles or virus-infected cells. Interactions between 
immune lymphocytes and virus-infected cells have been demon- 
strated in vitro using different viruses [S-1 s]. In this study 
we established an in vitro system t o  show cytotoxic actions 
of spleen celb from vaccinia virus-infected mice against vac- 
cinia-infected target cells. We investigated: (a) the kinetics of 
in vivo production of cytotoxic lymphocytes (CL), (b) the cell 
type of the effector cell, (c) the interactions between anti- 
bodies and CL, (d) the virus specificity and the target cell 
specificity of the in vitro reaction. 
2. Materials and methods 
2.1. Viruses and animals used 
Vaccinia virus strain WR was propagated in Vero cells (Green 
African monkey kidney) cultivated in Eagle's medium supple- 
mented with 100 IU/ml penicillin, 100pg/ml streptomycin and 
10 %inactivated calf serum. Stock virus contained lo6 TCIDSO/ 
ml. Herpes simplex virus type I was grown in Vero cells; the stock 
virus was equilibrated to 1 O6 TCIDSO /ml. Titration of virus 
was performed in Vero cells using the microtiter system 
(Greiner, Nurtingen, No 220 ART) with eight wells for every 
logarithmic dilution step. Reading was performed according 
t o  the method of Reed and Muench. Mice of the inbred 
strains C3H/TIF and DBA/2 (purchased from G.L. Bomholt- 
gird, Ry Denmark) were used throughout the study. 
2.2. Lymphoid cell suspensions 
\ 
Lymphocytes were obtained from the mouse spleens at  dif- 
ferent times after injection of 1-2 ml 10' - 1 O6 TCIDSO/ml 
of vaccinia virus, herpes simplex virus or Eagle's medium. Cell 
suspensions from spleens were obtained by the following 
procedure: spleens from five mice were aseptically removed, 
homogenized by hand with one gentle stroke in a IS ml glass 
homogenizer (Tenbroeck) containing I0 ml Eagle's medium 
supplemented with 10 % fetal calf serum, 1 % L-glutamin 
(200 mmoles), 1 76 50-fold concentrated amino acids (Micro- 
biological Assoc., Bethesda, Md., N o  13-606), 100 IU/ml peni- 
cillin and 100 pg/ml streptomycin. The suspension was trans- 
ferred t o  a tube, underlayed with calf serum and incubated for 
5 min at 4 "C to  remove spleen debris and clumped cells. The 
supernatant was removed and underlayed again with serum and 
the cells were pelleted by centrifugation for 10 min with 250 x g 
at 4 "C. The supernatant containing smooth debris was dis- 
carded. The cells were resuspended and viability was tested 
by trypan blue exclusion. Depletion of erythrocytes was per- 
formed by Ficoll-Isopaque discontinous gradient centrifuga- 
tion according t o  the method of Boyum [ 161. Adherent cells 
were removed by passing the spleen cells through a column of 
siliconed glass beads according t o  the method of Shortman 
et al. [ 171. The efferent cell population was free of macro- 
phages as was confirmed by Giemsa staining. 
2.3. B cell elimination 
Immunoglobulin-bearing cells were separated by adherent 
properties. Spleen cell suspensions were first incubated in 
nylon wool columns for 45 min at 37  "C and then washed 
slowly with warm medium according to  the method of Julius 
et al. [ 181. The decrease of the percentage of Ig-bearing cells 
was controlled by direct immunofluorescence staining with 
fluorescein isothiocyanate-conjugated rabbit anti-mouse Ig 
(Microbiological Assoc., N o  5 1-792). The amount of labeled 
cells of the effluent cell fraction was 1 %, while the  unfrac- 
tionated cell suspensions contained 45-50 % Ig-bearing cells. 
Elimination of B cells was also tested by the capability of 
lymphocytes t o  respond to  mitogens [ 191. The response t o  
phytohemagglutinin (PHA) (Wellcome, Buckingham, Kent) 
pokeweed mitogen (PWM) (Grand Island Biol. Co., Grand 
Island, N.Y. Cat. N o  536) and lipopolysaccharide W (LPS) 
(Difco, Detroit, Mich., Cat. No 31 22-25) was studied by 
[ 3  Hlthymidine incorporation. While there were no significant 
alterations of PHA transformation ratios, a significant reduction 
of transformation by PWM and LPA wasobtained in the B 
cell-depleted cell fraction. 
Elimination of B cells was performed by incubation with 
goat antiserum to mouse Ig (Gibco, BCL 1039). The serum 
was absorbed with C3H mouse thymocytes until there was 
no more cytotoxicity against thymocytes. 15 x 1 O6 cells were 
incubated in 0.2 ml of antiserum 30 min in 37 "C, washed 
and incubated again with an equal volume of guinea pig com- 
plement absorbed with mouse liver powder. 
2.4. T cell elimination 
Anti-@ serum from AKR mice was kindly provided by Dr. 
Rollinghoff, Mainz. 1 5  x l o 6  spleen cells were incubated in 
0.2 ml anti-@ serum for 30 min at 37 "C. Controls were run 
with normal mouse serum. The cells were washed and resus- 
pended in 0.2 ml guinea pig complement absorbed with 
mouse liver powder and agarose [ 201. After incubation for 
30 min at 37  "C the cells were washed and resuspended to  
the desired concentration. The viability of the cells was tested 
by the trypan blue exclusion test. 
2.5. Anti-vaccinia serum 
Hyperimmune serum was obtained from sensitized rabbits 
injected intracutaneously with 5 ml 1 O6 TCIDso/ml followed 
6- 10 weeks later by booster intravenous injections of the 
same dosage. Syngeneic hyperimmune serum was obtained 
from mice after three intraperitoneal injections of 2 ml 1 O6 
TCIDso/ml given at  two week intervals. The animals were 
bled one week after the last injection. Normal serum was 
obtained from noninfected animals. All sera were inactivated 
and stored at -70 "C. 
2.6. Target cells 
L-929 cells, kindly provided by Dr. Lehmann-Grube, Ham- 
burg, were grown as  monolayers in MEM containing 10 % 
FCS and 100 pg/ml of penicillin and streptomycin in Roux 
bottles. Mastocytoma P-8 15-X2 suspension cultures were 
grown in 10 cm Petri dishes containing Dulbecco's fortified 
Eagle's medium (Grand Island Biological Co.) with 10 % FCS 
and antibiotics, on  a rocker platform (Bellco Glass Co, Vine- 
land, N.Y.) in a humidified 8 % C02-atmosphere. 
2.7. Infection of target cells 
Monolayers of L-929 cells were trypsinized, suspended in 
fresh medium and plated in 0.1 ml volumes in sterile flat 
bottom microtest plates (Greiner, Nurtingen N o  220 ART) 
t o  reach a final concentration of 5 x 1 O4 cells/well. Five 
hours later the medium was removed and the cells were incub- 
ated with 0.2 ml virus suspension containing 5 x 1 O5 TCIDso/ 
0.2 ml medium. Two hours later all the supernatants were 
discarded and fresh medium was added. Suspensions of 
mastocytoma P-815-X2 cells were infected by incubating the 
cells in a medium containing 10 TCIDSO of virus per masto- 
cytoma cell under constant rocking. After 2 h the cells were 
washed and resuspended in fresh medium. 
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Five times 1 O6 infected o r  noninfected mastocytoma cells 
were suspended in 0.2 ml medium and 100 yCi "Cr (sodium- 
chromat, Amersham, Buchler, Braunschweig N o  CJSlP.  spec. 
activity 100-200 mCi/mg Cr) was added. After 2 h incuba- 
tion the cells were washed three times, resuspended to  the 
required concentration and dispensed in microtiter wells t o  a 
final concentration of 5 x 1 O4 cells/well. Infected or  nonin- 
fected L-929 monolayers were labeled by adding 1 yCi Cr 
to  each well. After 2 h incubation the monolayers were gently 
washed three times. 
2.8. Cytotoxic assay 
The assay is a modification of the technique described by 
Brunner et al. [21]. Lymphocytes and target cells were in- 
cubated in sterile flat bottom microtiter plates with a volume 
of 0.25 ml per well a t  37 "C in an atmosphere of 8 % COz 
and 92 76 air. Lymphocytes from infected and control mice 
were added t o  the Cr-labeled normal or infected target 
cells usually reaching a final ratio of 100 spleen cells to  1 
target cell in a volume of 0.2 ml. Routinely, 5 x lo6  spleen 
cells were added to  5 x 1 O4 target cells. If the  number of 
immune spleen cells was less than 5 x 1 06, the requisite num- 
ber of cells from noninfected animals was added t o  give the 
required count of 5 x lo6 lymphocytes. 
Following incubation for 4-20 h the microplates were cen- 
trifuged at 1000 rpm for 5 min. 0.1 ml of cell-free super- 
natant was gently removed and the residual 0.1 ml volume 
was harvested by vigorous pipetting t o  suspend the adherent 
cells. The volumes containing cell-free supernatant or super- 
natant with cells were counted and "Cr release in the whole 
supernatant was calculated using the formula: 
counts in supernatants - background counts 
counts in whole supernatant + cells - background counts 
Release = x 100 
The percentage of specific cytolysis of infected target cells was 
calculated by subtracting from the percentage Cr released 
in the presence of immune spleen cells that percentage of 
"Cr released by the same number of cells from noninfected 
animals. 
3. Results 
3.1. Infection conditions 
The infection of mastocytoma and L-929 cells with 10 TCIDSO/ 
cell vaccinia virus induces cytolysis. In the L cells, which were 
grown as monolayers, the infection led t o  the appearance of 
round cells after 4 h, followed by aggregation of cells after 
9-10 h and later on, to  reduced adherence of the infected 
cells t o  the surface. Loss of the Cr label was modest and 
generally did not exceed 5-25 76 after 30 h, while nonin- 
fected L-929 cells showed spontaneous release between 
10-20 76 (Table I ) .  A significant increase of infectivity titer 
was observed after 30 h. The mastocytoma P-8 1 5 x 2  suspen- 
sion cultures had a similar spontaneous "Cr release after 
infection (Table 5). The infected cells could be used 2 h after 
infection, but often higher percentage of specific cell cyto- 
lysis by immune lymphocytes could be obtained with cells 
infected for a longer period. Twelve hour infected cells were 
usually utilized as targets. 
The development of early virus-specific antigens after vaccinia 
virus infection has already been described [22]. We could 
observe specific surface immunofluorescence in infected 
L-929 or mastocytoma P-815-X2 cells, beginning 2 h after 
infection, using human anti-vaccinia hyperimmune sera. 
Fluorescence was more pronounced and visible o n  a higher 
percentage of cells in later stages of infection, reaching a per- 
centage of 70-80 % of labeled cells. 
3.2. Effects of sensitized lymphocytes o n  infected target cells 
C3H/TIF mice were infected intraperitoneally with 2 ml Eagle's 
medium containing 1 O6 TCIDSo/ml vaccinia virus. Control 
animals received virus-free medium. Six days later the mice 
were sacrificed, the spleens of 5 mice from each group were 
pooled and spleen cell suspensions were prepared. The cells 
were incubated for 20 h with "Cr-labeled, infected and non- 
infected L-929 cells and the "Cr release was calculated. Incu- 
bation of spleen cells from sensitized mice with vaccinia virus- 
infected target cells led t o  significant chromium release, while 
noninfected targets remained unaffected. Control spleen cells 
did not relevantly affect the target cells (Table 1). 
Table 1. Cytotoxic effecta) of C3H lymphocytes against vaccinia 
virus-infected L-929 cells 
Target cells 
Lymphocytesb) Infectedc) Noninfected 
Va& virw 82.4 f 3.4d) 36.6 f 0.3 
infected spleen 
Normal spleen 28.2 f 2 4  30.0 f 1.7 
Nil 24.5 f0.7 17.5 * 0.8 
a) Mean 70 51Cr release f. standard error of the mean from groups 
of 5 wells. 
b) Lymphocytes from a pool of 4-6 mice, purified by Ficoll-lso- 
paque gradient centrifugation. Mice were injected 6 days previous- 
ly with 1 ml 1 x 106 TCIDSO/ml vaccinia virus i.p. Ratio lympho- 
cytes: targets = 1OO:l. 
TCID50/0.2 ml of vaccinia virus for 2 h at 37 OC, then incubated 
in complete medium. 
d) Significantly greater slCr release from virus-infected L-929 cells 
by immune lymphocytes compared to normal lymphocytes 
(P  < 0.001); significantly greater 5lCr release by immune lym- 
phocytes from infected L-929 cells compared to noninfected 
L-929 cells (P < 0.001). 
c) 5 x 104 L-929 cells/well infected 12 h previously with 5 x lo5 
3.3. Virus specificity of infected target cell lysis 
C3H mice were injected with 1 x l o 7  viable BCG organisms 
(Behring-Werke, Marburg), 1 ml MEM containing 1 x 1 O6 
TCID,o/ml herpes simplex virus type I, 1 ml MEM containing 
1 x lo6 TCIDSo/ml vaccinia virus or Eagle's medium alone. 
The spleen cells were harvested 6 days later and incubated 
for 20 h with either vaccinia virus-infected or noninfected 
L-929 cells. Only cells from vaccinia virus-sensitized animals 
were able t o  lyse the infected target cells in significant amounts 
(Table 2). 
3.4. Time course of development of cytotoxic lymphocytes 
C3H mice were injected with 2 ml containing 1 x I O s ' 4  TCIDSo/ 
ml vaccinia virus. Beginning 2 days after injection, groups of 
5 infected or mock-infected animals were killed and the cyto- 
toxicity test was performed. Occurrence of CL could be 
observed after 2 days, reaching a maximum after one week 
and declining in the second week after infection (Fig. I ) .  At 
day 12 only weak cytotoxicity remained. 
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Table 2. Specificity of vaccinia virupinfected target cell lysisa) 
LylsphocyceSb) Infected L-929 cells 
M r P d e s n  6.0 f 1.7 
Vaccintr v i r w 4 d " e d  58.2 f 1.2C) 
rphn 
Hapg rtmplex viw 5.0 f 2.0 
infected aphn 
Bccinfscted spleen 12.5 f 3.1 
a) Mean % 51Cr release 2 SEM, 5 wells per group. 
b) Lymphocytes from a pool of 6 mice/group. Mice were injected 
intraperitoneally 6 days previously with 1 ml 1 x 106 TCIDm/ml 
vaccinia virus, 1 ml 1 x lo6 TCID5o/ml herpes simplex virus type 
I or 1 ml containing lo7  viable BCG organisms. Ratio lympho- 
cytes: infected target cells= 1OO:l. 
c) Significant W r  release (P < 0.001). No  significant slCr release 
in the other groups. 
, 
i \ // \ 
3 6 9 12 
DAYS POST I N F E C T I O N  WlIH VACCINIA VIRUS 
Figure 1.  Time dependence on the appearance of cytotoxic effector 
cells in v i m  Percent specific 5lCr release from mouse spleen cells 
harvested at different intervals after intraperitoneal injection of 2 ml 
105.4 TCIDdml vaccinia virus. Release of normal spleen cells was 
subtracted. Each point represents the mean of 5 wells f 2 SEM, l ym 
phocyte: target cell ratio = 1OO:l. 
3.5. In vitro kinetics of target cell lysis 
The following experiment was performed using a constant 
ratio (100: 1) of lymphocytes  t o  target cells. Spleen lympho- 
cytes were obtained from 6-day infected C3H mice and  con- 
trol animals. While the total  amoun t  of lymphocytes  was 
kept constant,  different percentages of lymphocytes  f rom 
sensitized animals were mixed with normal  lymphocytes  and 
incubated with the target cells. At intervals of 5 h the  reac- 
tions were s topped and the  "Cr release was tested.  Specific 
lysis could be observed as early as at  5 h incubation. T h e  
increase of Cr release takes a nearly linear course when 
correlated with t ime. The  t ime-dependent increase of 
release is consistent with the percentage of sensitized lympho- 
cytes in the reaction (Fig.  2). 
Cr 
The ratio of 100 lymphocytes  to 1 target cell seems t o  be 
the optimal concentration of effector cells t o  targets. Further  
additions of semit i led lymphocytes  to a constant number 
of target cells exceeding the rat10 100: 1 d o  not  lead t o  a n  
increase of chromium release (Fig. 3). In some experiments  
a slight dccrease of Cr release could be  observed a t  ratios 
over 100: 1 .  
3.6. Effect of anti-vaccinia antibodies on vaccinia virus- 
infected target cell lysis 
Incubation of infected target cells with human anti-vaccinia 
antibody together with agarose-absorbed guinea pig comple- 
ment for 2 0  h resulted in only slight cytolysis. Antibody or 
Eur. J. Immunol. 
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HOURS OF INCUBATION 
Figure 2. Kinetics of target cell lysis in virro. Number of target cells 
(L-929, vaccinia infected): 5 x 104/well. Number of lymphocytes: 
5 x 106lwell. Mixtures of normal lymphocytes with lymphocytes 
from mice immunized 6 days previously; 5% 51Cr release was mea- 
sured at intervals of 5 h. Each point represents the mean of 5 wells 
Percentage of immune lymphocytes: (0-c) 25, (.-=) 50, (0- 1 )  
75, and (0 -0)  100. 
100 1 
* '  
0 1251 251 501  100 1 200 1 
PERCENTAGE OF IMMUNE S P L E E N  CELLS 
+--/Ir 
rn TO I A R F E T  CELLS 
Figure 3. SlCr release with different lymphocytes to target cell ratios. 
Increasing numbers of lymphocytes from 6day immunized mice 
were incubated with a constant number (5 x lo4) of vaccinia virus- 
infected L-929 cells. Each point represents the mean of 5 wells 
complement alone had no cytotoxic  effect. The incubation 
of infected target cells, specific antibodies and sensitized 
lymphocytes  together for 20 h led t o  a significant reduction 
of '' Cr release. This blocking effect of antiserum could also 
be obtained using rabbit hyperimmune serum or syngeneic 
hyperimmune serum from C3H mice. Normal serum had no 
blocking activities (Table 3). 
3.7.  Characterization of the effector cell 
In the  in vitro system virus-specific cytolysis of vaccinia-in- 
fected target cells could be obtained with spleen cells and 
peritoneal exudate  cells f rom vaccinia virus-infected animals, 
while normal cells had no effect. Immune  spleen lymphocytes 
were incubated with anti-mouse lg for  30 min, washed and 
reincubated with absorbed guinea pig complement.  This pro- 
cedure led t o  a 46 % killing of Ficoll-Isopaque purified cells. 
Spleen cell cytotoxici ty  was not found t o  be reduced signi- 
ficantly. Likewise the elimination of Ig-bearing cells by  
adherent properties in a nylon wool column had no effect on 
the cytolytic activity of  the effluent cell fraction. 
A glass bead column was used t o  eliminate macrophages. The 
removal of macrophages had no effect on target cell lysis. 
These results suggest that  cells with adherent properties. 
including macrophages and  B cells, and  equally Ig-bearing 
cells such as B cells and o the r  cells with surface adsorbed 
immunoglobulins, for example macrophages coated with 
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Table 3. Effect of anti-vaccinia antibodies on lymphocyte-mediated 
lysisa) of vaccinia virus-infected L-929 target cells 
Exp. Lymphocytes Serum SlCr release 
f 5 )  










human + guinea pig 
complement 
Immune spleen Normal rabbit 
7, Immune spleen Normal human 
Norm1 spleen Normal human 
77.0 f 1.3 
35.0 f 1.6*) 
66.5 f 0.9 
34.5 f 1.0d) 
77.3 f 0.8 
27.3 f 1.4d) 
31.0 f 1.1  
26.3 * 1.2 
30.6 2 1.8 
a)  Lymphocytes from 6-day previously infected mice. Ratio lym- 
phocytes: target cells 100:1, mean % 51Cr release * SEM, 3 wells 
per group; 
b) Serum obtained after 3 injections of 1 ml 1 x 106 TCIDw/ml 
or 5 ml 1 x 106 TClDSolml (rabbit) vaccinia virus. 
c) Hyperimmunglobulin (Vacciniabulin, ImmunoR) 48 h dialyzed 
against phosphate buffered saline, then diluted 1:s in MEM. 
d) Significant inhibition of 51Cr release by immune mouse (P < 0.001), 
rabbit ( P  < 0.001) and human (P < 0.001) sera. 
cytophilic antibodies, are no t  responsible for  vaccinia virus- 
specific target cell killing. 
After incubation of cells with anti@ serum and then  with 
complement,  3 2  70 of cells were dead, calculated by t rypan 
blue exclusion. The t reatment  of spleen cell or peritoneal 
exudate cells with anti-@ serum and complement  resulted 
in  significant reduction o f  target cell killing. Treatment  with 
anti@ serum without complement is not  followed by  reduc- 
tion of " Cr release (Table 4). 
Table 4. Classification of the cytotoxic lymphocyte 
Treatment of immune 5~ release') 
lymphocytesb) from infected L-929 cells 
(%,I 
Lhtrmted 52.0 f 0.8 
Nylon wool column 53.0 f 2.0 
adsorption 
Glass bead column 48.9 f 1.6 
adsorption 
Antkmouue Ig + C 41.6 2 1.2 
Ant- serum + C 17.2 f 2.3c) 
A n t i e  serum without C 45.5 f 0.9 
a )  Mean 76 slCr release, SEM from groups of 5 wells. 
b) Lymphocyte from 6-day infected mice, lymphocyte: target 
cellratio = 50:l. 
c) Significant reduction (P < 0.001) of target cell lysis after 
pretreatment of lymphocytes with anti-@ serum and complement. 
3.8. Effect of  target cell specificity on virus-specific lympho- 
cy te  cytotoxici ty  
Sensitized lymphocytes  f rom C3H mice were able t o  kill vac- 
cinia-infected L-929 cells; t he  noninfected cells usually were 
not affected. When lymphocytes  f rom DBA/2 mice were used, 
the vaccinia-infected L-929 cells were no t  killed b y  the nor- 
mal or the  immune lymphocytes.  Likewise the immune 
lymphocytes f rom C3H mice n o  longer had cytolyt ic  activi- 
ties on vaccinia-infected mastocytoma P-8 I 5 x 2  target cells. 
Immune  cells f rom C5 7BL/6J mice had no significant effects 
on vaccinia infected L-929 cells or vaccinia-infected masto- 
cytoma P-815-X2 cells (unpublished data).  When a cross-reac- 
t ion was performed using cells from normal and infected C3H 
and DBA/2 mice against infected and noninfected L-929 and 
mastocytoma P-8 15x2 target cells. C3H lymphocytes  only 
lysed infected L-929 cells, while DBA/2 lymphocytes  only 
lysed the infected mastocytoma P-8 1 5 x 2  cells (Table 5). 
Since C3H mice and  L-929 cells share t h e  same H-2k antigen 
and DBA/2 mice have the same H-2d antigen as d o  mastocy- 
toma P-815-X2 cells, it could be  concluded that vaccinia 
virus-specific lymphocyte  cytotoxicity for target cells is 
dependent on transplantation antigen compatibilities. 
Table 5. Percent 51Cr releasea) from vaccinia virwinfected and now 
infected target cells by CL from normal and vaccinia virupinfected 
miceb) 
Mastocytom P815-X2 Spleen L-929 
lymphocytes Infected Noninfeded lnfeded Noninfeded 
24.721.1 13.1f2.3 24.1k1.3 21.0f1.6 None 
immune 77.0 f 1.2c) 33.5 f 0 . 9  13.0 f 1.5 5.6 f 0 . 4  
normal 28.3f2.7 30.8f0.7 10.4fl.Z 1.820.4 
immune 19.2f2.8 32.251.8 60.6f1.6C) 2.0f0.3 
normal 16.0f3.2 20.2f3.1 12.4k1.0 2.420.5 
5lCr release (%) 
C3H (H-Zk) 
DBA/2 (H-2d) 
a) Mean of 5 wells SEM in each group. 
b) Mice were injected intraperitoneally 6 days previously with 1 ml 
106 TCID5o/rnl of vaccinia virus. 
c) Significantly greater 51Cr release (P < 0.001) of immune lympho- 
cytes against syngeneic infected target cells compared to the ac- 
tion of normal cells, or t o  the action of immune lymphocytes 
against allogeneic infected and noninfected target cells. 
4. Discussion 
Most systems in which specific killing of virus-infected target 
cells by immune lymphocytes  has been described, work with 
viruses which themselves have n o  o r  only slight cytolyt ic  
effects on  the  target cells. Recently, virus-specific cytotoxicity 
could also be  demonstrated in an acute virus infection which 
leads to virus-induced target cell destruction [ 141. Vaccinia 
virus infection eventually results in target cell destruction, 
so that t he  incubation t ime for  t he  in vitro experiment is 
limited. In spite of this restriction it is a good model to study 
the  in vitro actions of immune effector cells. 
The  t ime course of development of C L  in ou r  experiments 
was similar t o  o the r  experimental  systems investigating cyto- 
toxic effects o n  cells infected with different viruses [ 12, 151. 
O n e  can suggest that  t h e  appearance and disappearance of 
cytotoxic  lymphocytes  take a regular course, but  there  is n o  
information as t o  what  happens t o  this effector cell population 
af ter  t h e  decrease of  cytotoxicity t w o  weeks af ter  infection. 
It is no t  clear if these cells are identical t o  those that  show 
antigen-specific blast transformation and release of factors. 
The  appearance of lymphocytes  which develop specific blast 
transformation t o  vaccinia virus seems t o  be delayed com- 
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pared with the appearance of cytotoxic cells. In t ransfoma- 
tion experiments with lymphocytes from vaccinated persons 
n o  booster effect in blast transformation after revaccination 
could be observed [23], while there was an increase of inter- 
feron production [ 241. Experiments are under study investi- 
gating the possibility of  reactivating cytotoxic lymphocytes 
in vivo after reinfection. 
The kinetic studies show that the rate of target cell lysis is 
augmented constantly with time and with increasing num- 
bers of CL. The results represented here are virus-specific; 
CL from animals infected with herpes simplex virus type I 
or viable BCC organisms have no effect on  vaccinia virus- 
infected target cells. A second argument for virus specificity 
is the blocking effect of anti-vaccinia antibody. Blocking 
could be achieved with antibodies from different species. It 
was not possible to  show a blocking effect when the ectro- 
melia virus was used in the same system. The possibility of 
recognizing antigens of different complexity by B and T cells 
[25], competition of T cells and antibodies for the receptor 
or merely insufficient concentration of antibodies were dis- 
cussed. We suggest that inadequate concentrations of anti- 
bodies may have led t o  negative results, since dilution of  
antibody t o  1 :25 resulted in only minimal inhibition. On 
the other hand one has t o  take into account that antibodies 
which are capable of neutralizing the infective virus may 
differ in their activity against virus-specific surface antigens. 
It has been demonstrated that antibodies can be raised which 
are directed only against virus-specific surface antigens or viral 
structural antigens of vaccinia virus [26]. It has, however, t o  
be elucidated if antibodies, which are directed solely against 
viral structural antigens, are able t o  block the action of CL. 
The studies with purified T cells after the elimination of B 
cells and macrophages using adherent properties, as well 
as the effects of anti-Ig antibodies and anti-@ serum, lead t o  
the suggestion that the T cell alone is the effector cell which 
is able to  lyse the infected target cell, in the absence of B 
cells, antibodies, complement or other soluble factors. The 
results are consistent with the findings of other investigations 
in which the cell type of CL against virus-infected cells [ 13, 
14, 271 or  cells differing by transplantation antigens o r  turnor- 
associated transplantation antigens could be characterized as  
a T cell [28, 291. 
It seems obvious that CL play a role in host resistance t o  viral 
infections, but the importance of this effect remains t o  be 
defined. It has been shown recently that in an acute infection 
with sindbis virus, CL have no effect on virus clearance [ 141. 
Virus clearance could be attributed t o  the  action of macro- 
phages which may act in an activated state or be “armed” by 
immune T cells [30] with or  without the help of antibodies 
or lymphocytes [3 I ] .  In the vaccinia system we could show 
that clearance of virus in virro is possible without the cyto- 
lysis by CL (manuscript in preparation). 
In our experimental system CL from C3H mice could only 
kill infected L cells but not infected or  noninfected masto- 
cytoma P815-X2 cells. The action of CL from DBA/2 mice 
was also specific; they had cytolytic effects only on infected 
mastocytoma cells. In a recent investigation it has been ob- 
served [ 151 that in the lymphocytic choriomeningitis system, 
target cell lysis was restricted t o  syngeneic or semiallogeneic 
systems. Since LCM is a budding virus it seems possible that 
this effect was caused by this type of virus maturation, fol- 
lowed by alteration of H-2 antigen concentration o n  the sur- 
face of infected cells [32]. The H-2 antigen-specific restric- 
tion of cytolysis in the  vaccinia system suggests that this re- 
striction is caused by a more general phenomenon. This is 
supported by the data of Shearer [33], showing cell-mediated 
cytotoxicity to  trinitrophenyl-modified lymphocytes in a 
syngeneic system. In another pox virus system using ectro- 
melia virus, different CL activities on  various-infected cells 
were interpreted as  different expressions of viral surface anti- 
gens on  the  target cells [ 131. However, if one correlates the 
results of specific target cell destruction with H-2 antigen 
compatibility, there is a decrease of cytolytic effects con- 
sistent with increasing antigenic heterogenicity. Secondly, 
the infected mastocytoma cell was, in our system, just as 
lysable as the L cells under the prerequisite that the syn- 
geneic cytolytic effector cell was used. Other investigators 
communicated virus-specific lysis of heterologous infected 
target cells [5, 10,  111.  For these systems the T cell speci- 
ficity of the reaction has t o  be elucidated t o  exclude anti- 
body-dependent activities [34-371. On the other hand, one 
could also suppose that high concentrations of virus-specific 
antigens on  cell surfaces can be recognized in spite of foreign 
transplantation antigen structures. 
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H.R. MacDonald' Early detection of potentially lethal events in T cell- 
mediated cytolysis" 
Department of Immunology, Swiss 
Institute for Experimental 
Research, Lausanne 
Cancer The short-term kinetics of the interaction between mouse cytolytic T 
lymphocytes (CTL) and 'lCr-labeled target cells was investigated. It was 
found that addition of EDTA to mixtures of CTL and target cells instanta- 
neously blocked de nouo lytic interactions, but did not inhibit the release 
of "Cr from already damaged target cells. Using this information, a modi- 
fied cytolytic assay was developed. By applying this assay to  highly active 
CTL populations generated in secondary mixed leukocyte cultures, it was 
possible t o  detect appreciable target cell damage as early as 30 seconds after 
exposure t o  CTL. Quantitative studies demonstrated linear relationships be- 
tween cytolysis and time and between rate of cytolysis and cell number under 
these assay conditions. 
1. Introduction 
The specific in vitro destruction of 'lcr-labeled target cells 
by cytolytic thymus-derived lymphocytes (CTL) is a well- 
characterized model system in which t o  study t h e  efferent 
phase of cell-mediated immunity [ 11. At the  present time, 
however, studies of the mechanism of CTL-mediated cyto- 
lysis a t  the molecular level are restricted by the relatively 
long duration (3- 18 h)  of commonly used assay systems. 
In order t o  circumvent this problem, we have modified the 
cytolytic assay so as t o  restrict the interaction between CTL 
and target cells t o  very short time periods. The rationale for 
this modification is based o n  the earlier observation that the 
addition of ethylenediaminetetraacetic acid (EDTA) t o  mix- 
tures of CTL and target cells resulted in complete inhibition 
of 'lCr release if EDTA was added a t  the beginning of the  
assay period, but only partial inhibition when added at later 
times [2, 31. In view of the recent demonstration that 'lCr 
release may continue for several hours following inactivation 
of CTL by antibody and complement [4] or by heating to 
45 O C  [ 5 ] ,  a likely interpretation of the earlier results is that 
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EDTA prevents the de nouo initiation of target cell damage, 
but has n o  effect on the  release of "Cr from already damaged 
target cells. 
In the present study, the minimal duration of cell contact ne- 
cessary t o  initiate lethal target cell damage has been estimated 
by making use of this property of EDTA. In  particular, by 
applying this analysis to highly active CTL populations ge- 
nerated in secondary mixed leukocyte cultures (MLC-Imm) 
[ 6 ] ,  we have been able t o  detect appreciable target cell da- 
mage as early as 30 sec after exposure t o  CTL at  appropriate 
temperatures. Furthermore, the  rate of target cell damage 
has been found to proceed linearly with time under these ex- 
perimental conditions. The  significance of these findings for 
the utilization and interpretation of "Cr release assays will 
be discussed. 
2. Materials and methods 
2.1. Mice 
Adult female mice of the inbred strains C57BL/6 and DBA/2 
were supplied by the animal colony maintained at the Swiss 
Institute for Experimental Cancer Research, Lausanne, Switzer- 
land. Original breeding pairs were obtained from the Jackson 
Laboratories, Bar Harbor, Maine. 
2.2. Generation of effector cells 
Cytolytic thymus-derived lymphocytes (CTL) were generated 
in mixed leukocyte cultures (MLC) using C57BL/6 spleen 
cells as  responding cells and irradiated (1000 rads) DBA/2 
spleen cells as stimulating cells. A detailed description of the 
culture conditions has been published elsewhere [6] .  In some 
